The Efficacy of Cognitive-Behavioral Therapy and Psychodynamic Therapy in the Outpatient Treatment of Major Depression: A Randomized Clinical Trial

被引:135
|
作者
Driessen, Ellen [1 ]
Van, Henricus L.
Don, Frank J.
Peen, Jaap
Kool, Simone
Westra, Dieuwertje
Hendriksen, Marielle
Schoevers, Robert A.
Cuijpers, Pim
Twisk, Jos W. R.
Dekker, Jack J. M.
机构
[1] Arkin Mental Hlth Care, Amsterdam, Netherlands
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2013年 / 170卷 / 09期
关键词
SUPPORTIVE PSYCHOTHERAPY; METAANALYSIS; PHARMACOTHERAPY; SYMPTOMATOLOGY; SEVERITY; ADULTS;
D O I
10.1176/appi.ajp.2013.12070899
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The efficacy of psychodynamic therapies for depression remains open to debate because of a paucity of high-quality studies. The authors compared the efficacy of psychodynamic therapy with that of cognitive-behavioral therapy (CBT), hypothesizing nonsignificant differences and the noninferiority of psychodynamic therapy relative to CBT. Method: A total of 341 adults who met DSM-IV criteria for a major depressive episode and had Hamilton Depression Rating Scale (HAM-D) scores >= 14 were randomly assigned to 16 sessions of individual manualized CBT or short-term psychodynamic supportive therapy. Severely depressed patients (HAM-D score >24) also received antidepressant medication according to protocol. The primary outcome measure was posttreatment remission rate (HAM-D score <= 7). Secondary outcome measures included mean posttreatment HAM-D score and patient-rated depression score and 1-year follow-up outcomes. Data were analyzed with generalized estimating equations and mixed-model analyses using intent-to-treat samples. Noninferiority margins were prespecified as an odds ratio of 0.49 for remission rates and a Cohen's d value of 0.30 for continuous outcome measures. Results: No statistically significant treatment differences were found for any of the outcome measures. The average posttreatment remission rate was 22.7%. Noninferiority was shown for posttreatment HAM-D and patient-rated depression scores but could not be demonstrated for posttreatment remission rates or any of the follow-up measures. Conclusions: The findings extend the evidence base of psychodynamic therapy for depression but also indicate that time-limited treatment is insufficient for a substantial number of patients encountered in psychiatric outpatient clinics.
引用
收藏
页码:1041 / 1050
页数:10
相关论文
共 50 条
  • [31] Effects of Religious Versus Conventional Cognitive-Behavioral Therapy on Gratitude in Major Depression and Chronic Medical Illness: A Randomized Clinical Trial
    Pearce, Michelle J.
    Koenig, Harold G.
    Robins, Clive J.
    Daher, Noha
    Shaw, Sally F.
    Nelson, Bruce
    Berk, Lee S.
    Belinger, Denise
    Cohen, Harvey Jay
    King, Michael B.
    JOURNAL OF SPIRITUALITY IN MENTAL HEALTH, 2016, 18 (02) : 124 - 144
  • [32] Cognitive-Behavioral and Psychodynamic Therapy in Adolescents with Social Anxiety Disorder: A Multicenter Randomized Controlled Trial
    Salzer, Simone
    Stefini, Annette
    Kronmueller, Klaus-Thomas
    Leibing, Eric
    Leichsenring, Falk
    Henningsen, Peter
    Peseschkian, Hamid
    Reich, Guenter
    Rosner, Rita
    Ruhl, Uwe
    Schopf, Yvonne
    Steinert, Christiane
    Vonderlin, Eva
    Steil, Regina
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2018, 87 (04) : 223 - 233
  • [33] Neuropsychological Predictors of the Clinical Response to Cognitive-Behavioral Therapy in Patients with Major Depression
    Kundermann, Bernd
    Hemmeter-Spernal, Julia
    Strate, Peter
    Gebhardt, Stefan
    Huber, Martin Tobias
    Krieg, Juergen-Christian
    Lautenbacher, Stefan
    ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2015, 26 (02) : 87 - 97
  • [34] Efficacy of cognitive-behavioral therapy for the prophylaxis of migraine in adults: a randomized controlled trial
    Klan, T.
    Gaul, C.
    Liesering-Latta, E.
    Both, B.
    Held, I.
    Witthoeft, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 94 - 95
  • [35] Efficacy and Mediators of a Group Cognitive-Behavioral Therapy for Hoarding Disorder: A Randomized Trial
    Tolin, David F.
    Wootton, Bethany M.
    Levy, Hannah C.
    Hallion, Lauren S.
    Worden, Blaise L.
    Diefenbach, Gretchen J.
    Jaccard, James
    Stevens, Michael C.
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2019, 87 (07) : 590 - 602
  • [36] Efficacy of cognitive-behavioral therapy for the prophylaxis of migraine in adults: a randomized controlled trial
    Klan, T.
    Gaul, C.
    Liesering-Latta, E.
    Both, B.
    Held, I.
    Witthoeft, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 63 - 63
  • [37] The efficacy of cognitive-behavioral therapy for older adults with ADHD: a randomized controlled trial
    Solanto, Mary V.
    Surman, Craig B.
    Alvir, Jose Ma. J.
    ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2018, 10 (03) : 223 - 235
  • [38] Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients
    Duarte, Priscila Silveira
    Miyazaki, Maria Cristina
    Blay, Sergio Luis
    Sesso, Ricardo
    KIDNEY INTERNATIONAL, 2009, 76 (04) : 414 - 421
  • [39] EFFECTS OF COGNITIVE-BEHAVIORAL THERAPY WITH PHYSICAL ACTIVITY PROMOTION ON IMMUNOLOGICAL MARKERS IN MAJOR DEPRESSION: A RANDOMIZED CONTROLLED TRIAL
    Euteneuer, Frank
    Schedlowski, Manfred
    Dannehl, Katharina
    Rief, Winfried
    PSYCHOSOMATIC MEDICINE, 2016, 78 (03): : A79 - A79
  • [40] Study design for a randomized clinical trial of cognitive-behavioral therapy for posttraumatic headache
    McGeary, Donald D.
    Penzien, Donald B.
    Resick, Patricia A.
    McGeary, Cindy A.
    Jaramillo, Carlos A.
    Eapen, Blessen C.
    Young-McCaughan, Stacey
    Nabity, Paul S.
    Moring, John C.
    Houle, Timothy T.
    Keane, Terence M.
    Peterson, Alan L.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 21